These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The effect of aldose reductase inhibition with ponalrestat on the width of the capillary basement membrane in diabetes mellitus. Ramirez LC, Arauz C, Pruneda L, Hammon K, Rosenstock J, Raskin P. Diabetes Res Clin Pract; 1991 Feb; 11(2):73-80. PubMed ID: 1902410 [Abstract] [Full Text] [Related]
8. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Pedersen MM, Schmitz A, Pedersen EB, Danielsen H, Christiansen JS. Diabet Med; 1988 Sep; 5(6):562-9. PubMed ID: 2850132 [Abstract] [Full Text] [Related]
9. Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus. Boland OM, Blackwell CC, Clarke BF, Ewing DJ. Diabetes; 1993 Feb; 42(2):336-40. PubMed ID: 8425670 [Abstract] [Full Text] [Related]
11. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat. Sima AA, Prashar A, Zhang WX, Chakrabarti S, Greene DA. J Clin Invest; 1990 May; 85(5):1410-20. PubMed ID: 2110189 [Abstract] [Full Text] [Related]
12. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman WR, Kilo C, Williamson JR. Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378 [Abstract] [Full Text] [Related]
13. Acute effects of a somatostatin analogue on kidney function in type 1 diabetic patients. Pedersen MM, Christensen SE, Christiansen JS, Pedersen EB, Mogensen CE, Orskov H. Diabet Med; 1990 May; 7(4):304-9. PubMed ID: 2140082 [Abstract] [Full Text] [Related]